Prognostic Value of the Immunological Subtypes of Adolescent and Adult T-Cell Lymphoblastic Lymphoma; an Ultra-High-Risk Pro-T/CD2(-) Subtype.

CD2 T-ALL/LBL T-LBL flow cytometry lymphoblastic lymphoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
15 Apr 2021
Historique:
received: 09 03 2021
revised: 09 04 2021
accepted: 12 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

(1) Background: T-cell lymphoblastic lymphoma (T-LBL) is extremely rare and highly aggressive, with no practical risk model defined yet. The prognostic value of T-LBL immunological subtypes is still a matter of controversy. (2) Methods: We re-evaluated 49 subsequent adult T-LBL patients treated according to the German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia (GMALL) protocols, 05/93 (

Identifiants

pubmed: 33921074
pii: cancers13081911
doi: 10.3390/cancers13081911
pmc: PMC8071379
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Blood. 2002 Jun 15;99(12):4379-85
pubmed: 12036865
Haematologica. 2019 Nov 28;106(1):163-172
pubmed: 31780634
Am J Clin Pathol. 2015 Jan;143(1):25-35
pubmed: 25511139
Acta Oncol. 2014 Jul;53(7):927-34
pubmed: 24913153
J Clin Oncol. 2017 Aug 10;35(23):2683-2691
pubmed: 28605290
Blood. 2016 Apr 14;127(15):1863-9
pubmed: 26747249
Blood. 2005 Apr 15;105(8):3072-8
pubmed: 15637138
Blood. 2004 Sep 15;104(6):1624-30
pubmed: 15178574
Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):498-505.e6
pubmed: 28647403
Exp Hematol. 2017 Jul;51:7-16
pubmed: 28412288
Clin Cancer Res. 2008 Feb 1;14(3):692-700
pubmed: 18245528
Nature. 1989 May 25;339(6222):312-4
pubmed: 2566919
Ther Adv Hematol. 2020 Jul 16;11:2040620720929475
pubmed: 32733662
Leukemia. 2003 Nov;17(11):2220-4
pubmed: 14576732
J Clin Oncol. 2016 Feb 20;34(6):572-80
pubmed: 26644537
Haematologica. 2020 Jun;105(6):e294-e297
pubmed: 31537688
Lancet Oncol. 2009 Feb;10(2):147-56
pubmed: 19147408
Blood. 2003 Aug 1;102(3):1000-6
pubmed: 12676784
Ann Hematol. 2012 Jan;91(1):73-82
pubmed: 21559811
Blood. 2009 Dec 10;114(25):5136-45
pubmed: 19828704
Hematol Oncol Clin North Am. 2000 Dec;14(6):1307-25, ix
pubmed: 11147225
Blood. 1999 Jun 1;93(11):3931-9
pubmed: 10339502
Blood. 2003 Sep 1;102(5):1745-52
pubmed: 12714509
Mod Pathol. 2018 May;31(5):732-743
pubmed: 29327714

Auteurs

Beata Ostrowska (B)

Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Grzegorz Rymkiewicz (G)

Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Magdalena Chechlinska (M)

Department of Cancer Biology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Katarzyna Blachnio (K)

Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Katarzyna Domanska-Czyz (K)

Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Zbigniew Bystydzienski (Z)

Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Joanna Romejko-Jarosinska (J)

Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Anita Borysiuk (A)

Flow Cytometry Laboratory, Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Sebastian Rybski (S)

Department, of Mathematical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Wojciech Michalski (W)

Department, of Mathematical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Jan Walewski (J)

Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

Classifications MeSH